BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 4075104)

  • 1. Ontogeny of tolerance to haloperidol: behavioral and biochemical measures.
    Coyle S; Napier TC; Breese GR
    Brain Res; 1985 Nov; 355(1):27-38. PubMed ID: 4075104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopamine metabolites and catalepsy after lithium and haloperidol.
    Bowers MB; Rozitis A
    Eur J Pharmacol; 1982 Feb; 78(1):113-5. PubMed ID: 7200429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conditional tolerance to haloperidol-induced catalepsy is not caused by striatal dopamine receptor supersensitivity.
    de Graaf CJ; Korf J
    Psychopharmacology (Berl); 1986; 90(1):54-7. PubMed ID: 3094062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopaminergic mediation of beta-endorphin-induced catalepsy.
    Van Loon GR; Kim C
    Res Commun Chem Pathol Pharmacol; 1978 Jul; 21(1):37-44. PubMed ID: 567367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention by (+/-)-8-hydroxy-2-(di-n-propylamino)tetralin of both catalepsy and the rises in rat striatal dopamine metabolism caused by haloperidol.
    Andersen HL; Kilpatrick IC
    Br J Pharmacol; 1996 May; 118(2):421-7. PubMed ID: 8735647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopamine, serotonin, and acid metabolites in brain regions from the developing offspring of ethanol-treated rats.
    Rathbun W; Druse MJ
    J Neurochem; 1985 Jan; 44(1):57-62. PubMed ID: 2578063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine increase in the prefrontal cortex correlates with reversal of haloperidol-induced catalepsy in rats.
    Tucci S; Fernandez R; Baptista T; Murzi E; Hernandez L
    Brain Res Bull; 1994; 35(2):125-33. PubMed ID: 7953768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regional rat brain levels of 3,4-dihydroxyphenylacetic acid and homovanillic acid: concurrent fluorometric measurement and influence of drugs.
    Westerink BH; Korf J
    Eur J Pharmacol; 1976 Aug; 38(2):281-91. PubMed ID: 954842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tolerance to haloperidol-induced increases in dopamine metabolites: fact or artifact?
    Finlay JM; Jakubovic A; Fu DS; Fibiger HC
    Eur J Pharmacol; 1987 May; 137(1):117-21. PubMed ID: 3609130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repeated testing of rats markedly enhances the duration of effects induced by haloperidol on treadmill locomotion, catalepsy, and a conditioned avoidance response.
    Hillegaart V; Ahlenius S; Magnusson O; Fowler CJ
    Pharmacol Biochem Behav; 1987 May; 27(1):159-64. PubMed ID: 3615537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sensitization versus tolerance to the dopamine turnover-elevating effects of haloperidol: the effect of regular/intermittent dosing.
    Csernansky JG; Bellows EP; Barnes DE; Lombrozo L
    Psychopharmacology (Berl); 1990; 101(4):519-24. PubMed ID: 2388975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Increased tolerance of the dopamine- and serotoninergic systems during chronic administration of haloperidol and levomepromazine].
    Allikmets LKh; Zharkovskiĭ AM; Otter MIa; Khinrikus TKh
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1979; 29(5):1067-70. PubMed ID: 573939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alterations in dopamine metabolism after chronic administration of haloperidol. Possible role of increased autoreceptor sensitivity.
    Saller CF; Salama AI
    Neuropharmacology; 1985 Feb; 24(2):123-9. PubMed ID: 3990917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of haloperidol-induced dopamine release in the rat striatum using intracerebral dialysis.
    Walters DE; Chapman CD; Howard SG
    J Neurochem; 1990 Jan; 54(1):181-6. PubMed ID: 2293609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bilateral neurochemical changes induced by unilateral cerebral haloperidol administration: evidence for cerebral asymmetry in the rat.
    Hyde JF; Jerussi TP
    Pharmacol Biochem Behav; 1992 Jul; 42(3):457-64. PubMed ID: 1409779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interrelationships between plasma homovanillic acid and indices of dopamine turnover in multiple brain areas during haloperidol and saline administration.
    Csernansky JG; Barnes DE; Bellows EP; Lombrozo L
    Life Sci; 1990; 46(10):707-13. PubMed ID: 2314192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of the synthesis and metabolism of striatal dopamine after disruption of nerve conduction in the medial forebrain bundle.
    Commissiong JW; Slimovitch C; Toffano G
    Br J Pharmacol; 1990 Apr; 99(4):741-9. PubMed ID: 2361171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in dopamine, serotonin and their metabolites in discrete brain areas of rat offspring after in utero exposure to cocaine or related drugs.
    Henderson MG; McMillen BA
    Teratology; 1993 Nov; 48(5):421-30. PubMed ID: 7508151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of clozapine, thioridazine, perlapine and haloperidol on the metabolism of the biogenic amines in the brain of the rat.
    Bürki HR; Ruch W; Asper H
    Psychopharmacologia; 1975; 41(1):27-33. PubMed ID: 235767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of neuroleptic drugs on striatal dopamine release and metabolism in the awake rat studied by intracerebral dialysis.
    Zetterström T; Sharp T; Ungerstedt U
    Eur J Pharmacol; 1984 Oct; 106(1):27-37. PubMed ID: 6085051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.